Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Monday, May 27, 2024 | Back issues
Courthouse News Service Courthouse News Service

Class Doubts Glaxo’s ‘Snore Relief’ Claims

BELLEVILLE, Ill. (CN) - GlaxoSmithKline subsidiary CNS pushes its "Breathe Right Snore Relief" throat spray with false claims, according to a class action in St. Clair County Court.

Named plaintiff Justin Swires says CNS makes a series of false claims for its product, that it: "(1) reduces loudness and frequency of snoring; (2) provides '30 quite [sic, recte quiet] nights'; (3) 'can help 85 percent of snorers get relief'; and (4) 'lubricates throat tissues to minimize vibrations and control the snoring sound.' However, in truth and fact, Snore Relief does none of these things."

Swires says the ads violate the Illinois Consumer Fraud and Deceptive Business Practices Act.

"CNS has no scientific or otherwise legitimate basis for making any of its efficacy claims," the complaint states. "As such, these claims are unfair, unjust, and deceptive."

Swires seeks class damages and disgorgement of all the money that class members paid for Breathe Right Snore Relief.

He is represented by John Campbell with The Simon Law Firm in St. Louis.

The complaint consistently misspells "Breathe Right" as "Breath Right."

Defendant CNS has no relationship with Courthouse News Service.

Follow @@joeharris_stl
Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.